Barely Significant
← all phrases

a slight trend

3,291 sentences · 3,291 papers · 4,853 search hits before verification · confirmed specimen

Sighted at

p<0.09

Listed by Hankins (2013) · Otte et al. (2022)

In the literature

We found similar outcomes for high and low tumour-infiltrating T-lymphocytes groups in terms of 5-year overall survival ( p = 0.46) ( Figure 1 ), 5-year disease-specific survival ( p = 0.88) ( Figure 2 ) and 5-year disease-free survival ( p = 0.73) ( Figure 3 ), although there was a slight trend towards improved survival in the high tumour-infiltrating T-lymphocytes group.
Quality of life scores On the MLWHF, there was no significant difference between the groups at any time point, although there was a slight trend towards the intervention group having slightly less deterioration over the six months in overall quality of life than the UC control group (mean difference +6.7 ± 16.2 vs +9.5 ± 10.8; p = 0.6).
Contrary to our expectations, the 72 h-exposure of the cells to glucotoxicity does not significantly increase the levels of p16 INK4a immunostaining irrespective of the cellular compartment, although a slight trend towards increase was found at 10 and 33 mM glucose compared to 5 mM glucose (Fig. 2 a−c).
Interestingly, on meta-analysis of non-selective NSAIDs, there was only a slight trend for IBD relapse, which was not statistically significant (relative risk 1.29, 95% confidence interval 0.92–1.80).
IBD considerations in spondyloarthritis.
Ther Adv Musculoskelet Dis · 2020 · PMC7350041
10 Concerns regarding secondary malignancies, such as acute myeloid leukemia and brain tumors, have been reported only in pediatric patients, with a slight trend favoring the control group. 10 Furthermore, there is a consideration that dexrazoxane may exacerbate myelosuppression caused by chemotherapeutic agents, as evidenced by a lower nadir in white blood cell count in the dexrazoxane group, although no significant differences were observed in the incidence rates of thrombocytopenia, neutropenia, and anemia. 10 Overall, the totality of available evidence robustly supports the use of dexrazoxane in adult patients at high risk for developing AIC.